Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 9909-9920
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9909
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9909
Ref. | No. of patients | Biliary abnormalities | First treatment | Follow-up | Further treatments | Complications/outcome |
Chaudhary et al[53], 1998 | 9 symptomatic | Stenosis: 2 CBD stones: 2 | BA 2 SRS 7 | 9 pts - | BA 2 Stent 1 ES + SE 2 | Death 1 Resolution 7 |
Condat et al[3], 2003 | 7 symptomatic | Cholecystitis/right hypocondrial pain 4 Cholangitis 1 Stenosis 2 | Cholecystostomy + ERCP 1 Stent 1 BA+PTBD 1 | 4-25 mo | - | Haemobilia 1 |
Gauthier-Villars et al[19], 2005 | 8 symptomatic (pediatric) | Stenosis 6 Biliarydilation 8 | - PSS 8 | 8 pts 4.5-15 yr | - | Complete resolution 7 Partial resolution 1 |
Khare et al[25], 2005 | 13 symptomatic | A: Stenosis 5 B: CBD stones 3 C: Stenosis + CBD stones 5 | A: PSS 4; BA 1 B: ERCP 2; PSS + BA 1 C: Unsuccessful ERCP 4; PSS 3; Splenectomy + devasc 2 | - | A: Multiple ERCP: 1 B: Splenectomy 1 (post-ERCP) C: Multiple ERCP 2; BA 1; Splenectomy + BA 1 | Death 1 |
Vibert et al[30], 2007 | 19 symptomatic | IE biliary dilation 9 IE stones 7 CBD stones 4 | PSS group: PTBD 1 SRS 10 NPSS group: ES + stent 2 ES + SE 1 PTBD 6 BA 4 | 19 pts 4-30 mo | PSS group: BA 5 NPSS group PTBD 1 after ERCP and 4 after BA | Resolution 17 Death 3 |
Dhiman et al[2], 2007 | 12 symptomatic | Stenosis: 7 CBD stones: 5 Choledochal varices 2 Mirizzi’ssyndrome 1 | PSS 5 ES 3 ES + dilation 2 Stent 4 | 19 mo (range 6-132) | Multiple stent exchange in pts initially treated with stent | Cholangitis in 2 pts treated with stent |
D’Souza et al[54], 2009 | 1 symptomatic | CBD stenosis + GB stones | Pre-surgery stent→PSS + BA (single stage) | 18 mo | - | Resolution |
Camerlo et al[51], 2010 | 3 symptomatic | Stenosis 3 | PSS 3 Stent 1 (pre-PSS) | 3 pts 2-13 yr | - | Resolution 3 |
Agarwal et al[55], 2011 | 39 symptomatic | Stenosis 15 CBD stones 7 GB stones 12 IE dilation 39 | SRS 37 BA 2 | 37 pts 32 mo | ES ± SE 10 BA 12 ES + cholecystectomy 1 | Resolution 35 |
Chattopadhyay et al[52], 2012 | 24 symptomatic 32 asymptomatic | CBD stenosis 3 Multiple stenosis 5 IE dilation 14 CBD stones 7 GB stones 11 | ERCP pre-surgery 12 PSS 40 Splenectomy + devasc. 16 | 43 pts 48 mo (range 14-120) | ES + SE 2 Multiple ES + stent 5 BA 2 | Resolution 38 Death 1 |
Suárez et al[56], 2013 | 3 symptomatic | Stenosis 3 | UDCA 1 BA 1 | - | - | - |
Bhatia et al[57], 2014 | 2 symptomatic | GB stones | Cholecistectomy | - | - | Resolution |
Liu et al[58], 2015 | 18 | Stenosis 6 Dilations 6 Stenosis + dilations 6 | PSS 18 | - | - | Resolution 15 |
- Citation: Franceschet I, Zanetto A, Ferrarese A, Burra P, Senzolo M. Therapeutic approaches for portal biliopathy: A systematic review. World J Gastroenterol 2016; 22(45): 9909-9920
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/9909.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.9909